Global Oncolytic Virus Therapy Competitive Landscape Professional Research Report 2025
Research Summary
Oncolytic virus therapy, also known as virotherapy, is a type of cancer treatment that utilizes genetically engineered or naturally occurring viruses to selectively target and destroy cancer cells. The viruses used in oncolytic virus therapy are designed to replicate within cancer cells, causing their death while leaving healthy cells unharmed. This therapy takes advantage of the natural ability of certain viruses to infect and replicate within cells. Oncolytic viruses can be modified to enhance their tumor targeting, safety, and anticancer effects. When administered to patients, these viruses selectively infect and replicate within cancer cells, leading to tumor cell lysis and the release of tumor-associated antigens. This process stimulates an immune response, promoting the recognition and destruction of both infected cancer cells and non-infected cancer cells. Oncolytic virus therapy has shown promise in preclinical and clinical trials for various types of cancer and may be used as a standalone treatment or in combination with other cancer therapies, such as chemotherapy, radiation, or immunotherapy. The field of oncolytic virus therapy continues to evolve, with ongoing research and clinical trials aiming to optimize the therapeutic potential and broaden the utility of this innovative treatment approach.
According to DIResearch's in-depth investigation and research, the global Oncolytic Virus Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Oncolytic Virus Therapy include Amgen, Oncolytics Biotech, Viralytics, Oncolys BioPharma, Transgene SA, Targovax, PsiOxus Therapeutics, SillaJenBiotherapeutics, Genelux Corporation, Sorrento Therapeutics, Lokon Pharma, Cold Genesys, TILT Biotherapeutics, Vyriad etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oncolytic Virus Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oncolytic Virus Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oncolytic Virus Therapy Include:
Amgen
Oncolytics Biotech
Viralytics
Oncolys BioPharma
Transgene SA
Targovax
PsiOxus Therapeutics
SillaJenBiotherapeutics
Genelux Corporation
Sorrento Therapeutics
Lokon Pharma
Cold Genesys
TILT Biotherapeutics
Vyriad
Oncolytic Virus Therapy Product Segment Include:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Oncolytic Virus Therapy Product Application Include:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oncolytic Virus Therapy Industry PESTEL Analysis
Chapter 3: Global Oncolytic Virus Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Oncolytic Virus Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Oncolytic Virus Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oncolytic Virus Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oncolytic Virus Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Oncolytic Virus Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oncolytic Virus Therapy Product by Type
- 1.2.1 HSV-based Oncolytic Viruses
- 1.2.2 Adenoviruses-based Oncolytic Viruses
- 1.2.3 Vaccinia Virus-based Oncolytic Viruses
- 1.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
- 1.2.5 Newcastle Disease Virus-based Oncolytic Viruses
- 1.3 Oncolytic Virus Therapy Product by Application
- 1.3.1 Melanoma
- 1.3.2 Prostate Cancer
- 1.3.3 Breast Cancer
- 1.3.4 Ovarian Cancer
- 1.3.5 Others
- 1.4 Global Oncolytic Virus Therapy Market Size Analysis (2020-2032)
- 1.5 Oncolytic Virus Therapy Market Development Status and Trends
- 1.5.1 Oncolytic Virus Therapy Industry Development Status Analysis
- 1.5.2 Oncolytic Virus Therapy Industry Development Trends Analysis
- 2 Oncolytic Virus Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oncolytic Virus Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oncolytic Virus Therapy Market Analysis by Regions
- 4.1 Oncolytic Virus Therapy Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Oncolytic Virus Therapy Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Oncolytic Virus Therapy Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Oncolytic Virus Therapy Revenue Forecast by Region (2026-2032)
- 5 Global Oncolytic Virus Therapy Market Size by Type and Application
- 5.1 Global Oncolytic Virus Therapy Market Size by Type (2020-2032)
- 5.2 Global Oncolytic Virus Therapy Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Oncolytic Virus Therapy Market Size by Type
- 6.4 North America Oncolytic Virus Therapy Market Size by Application
- 6.5 North America Oncolytic Virus Therapy Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Oncolytic Virus Therapy Market Size by Type
- 7.4 Europe Oncolytic Virus Therapy Market Size by Application
- 7.5 Europe Oncolytic Virus Therapy Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Oncolytic Virus Therapy Market Size by Type
- 8.4 China Oncolytic Virus Therapy Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Oncolytic Virus Therapy Market Size by Type
- 9.4 APAC (excl. China) Oncolytic Virus Therapy Market Size by Application
- 9.5 APAC (excl. China) Oncolytic Virus Therapy Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Oncolytic Virus Therapy Market Size by Type
- 10.4 Latin America Oncolytic Virus Therapy Market Size by Application
- 10.5 Latin America Oncolytic Virus Therapy Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Oncolytic Virus Therapy Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
- 11.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
- 11.5 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Oncolytic Virus Therapy Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Oncolytic Virus Therapy Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Oncolytic Virus Therapy Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Amgen
- 13.1.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Amgen Oncolytic Virus Therapy Product Portfolio
- 13.1.3 Amgen Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Oncolytics Biotech
- 13.2.1 Oncolytics Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
- 13.2.3 Oncolytics Biotech Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Viralytics
- 13.3.1 Viralytics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Viralytics Oncolytic Virus Therapy Product Portfolio
- 13.3.3 Viralytics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Oncolys BioPharma
- 13.4.1 Oncolys BioPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
- 13.4.3 Oncolys BioPharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Transgene SA
- 13.5.1 Transgene SA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Transgene SA Oncolytic Virus Therapy Product Portfolio
- 13.5.3 Transgene SA Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Targovax
- 13.6.1 Targovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Targovax Oncolytic Virus Therapy Product Portfolio
- 13.6.3 Targovax Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 PsiOxus Therapeutics
- 13.7.1 PsiOxus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
- 13.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 SillaJenBiotherapeutics
- 13.8.1 SillaJenBiotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 SillaJenBiotherapeutics Oncolytic Virus Therapy Product Portfolio
- 13.8.3 SillaJenBiotherapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Genelux Corporation
- 13.9.1 Genelux Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
- 13.9.3 Genelux Corporation Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Sorrento Therapeutics
- 13.10.1 Sorrento Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
- 13.10.3 Sorrento Therapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Lokon Pharma
- 13.11.1 Lokon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
- 13.11.3 Lokon Pharma Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Cold Genesys
- 13.12.1 Cold Genesys Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Cold Genesys Oncolytic Virus Therapy Product Portfolio
- 13.12.3 Cold Genesys Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 TILT Biotherapeutics
- 13.13.1 TILT Biotherapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
- 13.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Vyriad
- 13.14.1 Vyriad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Vyriad Oncolytic Virus Therapy Product Portfolio
- 13.14.3 Vyriad Oncolytic Virus Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Oncolytic Virus Therapy Industry Chain Analysis
- 14.2 Oncolytic Virus Therapy Industry Raw Material and Suppliers Analysis
- 14.2.1 Oncolytic Virus Therapy Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Oncolytic Virus Therapy Typical Downstream Customers
- 14.4 Oncolytic Virus Therapy Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook